Gene Therapy Development Summit
March 25 – 27, 2025 // Boston, Massachusetts
Join Worldwide Clinical Trials at the Gene Therapy Development Summit
4
days leftAbout event
Topic: CGT
We know that all trials are different. But with cell and gene therapy programs, that’s even more true. That’s why our Cell & Gene Therapy Hub is committed to providing you with a customized team to tackle your specific scientific, regulatory, medical, and operational needs. If you are attending Gene Therapy Development Summit, stop by booth #2 and say hello to our team.
Amy Raymond, Senior Director, Therapeutic Strategy Lead for Rare Disease & Cellular and Genetic Medicines, will be a panelist on the session “Optimizing Gene Therapy Programs for Patient Communities of Any Size” on March 26 at 4 PM EST, where she will discuss the following topics:
- Multi-stakeholder discussion of friction points in the development lifecycle and how to overcome them: what have we tried, what has been successful, and under what circumstances
- Dissection of real-world examples over time and across different patient communities
- Analysis of recent trends and their impacts to key strategies and tactics
Date
Tuesday to Thursday
March 25 – 27, 2025
Venue
The Westin Boston Seaport District
425 Summer St
Boston, MA 02210
Amy Raymond
Senior Director, Therapeutic Strategy Lead, Rare Disease & Cellular and Genetic Medicines
Dr. Raymond has been a drug discovery and development professional for 20+ years, including progressive roles in rare disease clinical operations and rare disease clinical strategy. Her clinical development experience spans all therapeutic areas and all stages of the clinical development lifecycle, from Natural History studies through in-patient Phase I trials, and Long-Term Follow Up and Post Marketing surveillances.
